AG Brown announces $17.85 million in settlements in ongoing drug price-fixing conspiracy case, new complaint against Novartis and subsidiaries
Washingtonians who paid for certain generic prescription drugs in the U.S. between May 1, 2009, and December 31, 2019, could be eligible for money